STXS — Stereotaxis, Inc.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1289340 ·
Last close
$1.26
Market Cap
$125.53M
52W High
$2.10
52W Low
$1.24
ADV30
1,157,922
Next earnings
2026-08-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 6,291,000 | 3,794,000 | -5,981,000 | -5,861,000 | 54,030,000 | 14,616,000 | 34,432,000 |
| Dec 2025 | 8,642,000 | 4,327,000 | -5,649,000 | -5,531,000 | 52,251,000 | 13,421,000 | 33,530,000 |
| Sep 2025 | 7,464,000 | 4,101,000 | -6,557,000 | -6,463,000 | 45,587,000 | 10,506,000 | 34,053,000 |
| Jun 2025 | 8,798,000 | 4,579,000 | -3,977,000 | -3,826,000 | 41,173,000 | 6,967,000 | 34,421,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-15,348,000
Investing CF
$-172,000
Financing CF
$19,447,000
CapEx
$-161,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.24
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-589,229,000
Inventory
$10,495,000
Receivables
$9,619,000
ST Investments
—
EBIT TTM
$-22,164,000
Pretax Income TTM
$-21,681,000
Interest Exp TTM
—
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$31,196,000
EBITDA
$-18,159,000
Free Cash Flow
$-8,817,875
Enterprise Value
$125,893,808
Total Cash
$14,616,000
Total Debt
$5,280,000
Shares Out
99,628,561
Trailing EPS
$-0.24
Book Value
$0.15
ROE
-156.1%
ROA
-24.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 32,377,000 | -22,112,000 | -21,643,000 | 52,251,000 | 33,530,000 | — | -13,685,000 |
| Dec 2024 | 26,918,000 | -24,739,000 | -24,045,000 | 46,724,000 | 35,292,000 | — | -8,497,000 |
| Dec 2023 | 26,771,000 | -21,839,000 | -20,713,000 | 41,909,000 | 19,989,000 | — | -9,139,000 |
| Dec 2022 | 28,147,000 | -18,776,000 | -18,292,000 | 53,413,000 | 21,484,000 | — | -8,415,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.13
Max Pain — expiry 2026-08-21
max pain strike: $2.50 · spot: $1.26 · call oi: 1,479 · put oi: 72
Expected Move to 2026-08-21:
±$1.24
(98.02%) —
implied range
$0.02 –
$2.49
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AVHHL | AVITA Medical, Inc. | $135.42M | $0.88 | — |
| RCEL | AVITA Medical, Inc. | $135.42M | $4.40 | — |
| MBOT | Microbot Medical Inc. | $115.52M | $1.72 | — |
| CVRX | CVRx, Inc. | $137.32M | $5.18 | — |
| STIM | Neuronetics, Inc. | $137.78M | $1.98 | — |
News headlines (Yahoo Finance, 1h cache)
Veracyte (VCYT) Q2 Earnings and Revenues Surpass Estimates
2026-07-30 22:00 · Yahoo
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
2026-07-21 13:00 · Yahoo
University of Szeged Pioneers First Robotic Cardiology Program in Hungary
2026-07-20 12:31 · Yahoo
Stereotaxis (STXS) Could Be 56% Undervalued After Shelf Registration Filings
2026-07-20 12:07 · Yahoo
Can ISRG Defend Its Leadership as Global Competition Intensifies?
2026-07-15 16:05 · Yahoo
ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?
2026-07-10 18:10 · Yahoo
Stereotaxis closes Robocath takeover
2026-07-09 17:00 · Yahoo
Stereotaxis Completes Acquisition of Robocath
2026-07-09 12:08 · Yahoo
Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Growth For Stereotaxis (STXS)
2026-06-30 02:04 · Yahoo
ISRG's Capital Placement Surge: Demand Strength or Upgrade Cycle Peak?
2026-06-15 14:31 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.